NCT00687973View on ClinicalTrials.gov

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hypertension
Interventions
DRUG

Valsartan/amlodipine 80/5 mg tablets

DRUG

Amlodipine 5 mg capsules

DRUG

Amlodipine 10 mg capsules

DRUG

Atenolol 50 mg tablets

DRUG

Atenolol 100 mg tablets

Trial Locations (1)

92506

2 & 4 rue Lionel Terray BP 308, Rueil-Malmaison

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY